NIH Awards UP Oncolytics $2.5 Million for Glioblastoma Therapy Development
The **National Institutes of Health** awarded **UP Oncolytics** $2.5 million in Phase II SBIR Fast-Track funding for a two-year effort to complete preclinical development of an engineered Zika-virus therapy and prepare an Investigational New Drug application. The research award builds on a prior $500,000 Phase I award and is not an open procurement, but future testing, manufacturing, and clinical-trial support needs may emerge if the program advances.